AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Recruitingn/aAges 40 Years - 55 YearsMaleInstitute of Cancer Research, United Kingdom
💬

In plain words

What the trial is, and whether it could suit you

The i4i PRODICT® study has been developed to investigate the uptake and acceptability of the i4i PRODICT® test which combines both common and rare genetic changes (genetic variants) into one saliva-based DNA test to estimate a person's future risk of prostate cancer (PrCa) in people of varying ethnicities.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * People with a prostate\* (PwP). \*People with a prostate is defined as people born male. * Aged 40 to 55 years. * People of either (i) Black African/Black African-Caribbean; (ii) White European; or (iii) South Asian or East Asian ancestry. These are defined as individuals with 4 grandparents of the same ancestry. * Absence of any psychological, familial, sociological or geographical situation potentially hampering compliance with the study protocol and follow-up schedule. Exclusion Criteria: * Previous diagnosis of prostate cancer. * People of mixed ancestry * Previous diagnosis of cancer with a life-expectancy of less than five years. * Negative prostate biopsy within one year before recruitment. * Any significant psychological conditions that may be worsened or exacerbated by participation in the study.
💊

What it tests

  • The i4i PRODICT® test.
  • Prostate cancer screening
  • MRI Scan
  • Prostate Biopsy
📍

Where

3 sites
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Sutton, United Kingdom
The Royal Marsden Hospital
London, United Kingdom
The Royal Marsden Hospital
Sutton, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy